YM155 reverses rapamycin resistance in renal cancer by decreasing survivin-Reference-Cited by-同舟云学术

YM155 reverses rapamycin resistance in renal cancer by decreasing survivin

Published:2014-06-11 Issue:10 Volume:140 Page:1705-1713
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Koike Hidekazu,Nitta Takashi,Sekine Yoshitaka,Arai Seiji,Furuya Yosuke,Nomura Masashi,Matsui Hiroshi,Shibata Yasuhiro,Ito Kazuto,Oyama Tetsunari,Suzuki Kazuhiro

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-014-1734-z.pdf

Reference37 articles.

1. Altieri DC (2003) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22:8581–8589

2. Altieri DC, Marchisio PC (1999) Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79:1327–1333

3. Asechi H, Hatano E, Nitta T et al (2010) Resistance to cisplatin-induced apoptosis via PI3 K-dependent survivin expression in a rat hepatoma cell line. Int J Oncol 37:89–96

4. Carew JS, Kelly KR, Nawrocki ST (2011) Mechanisms of mTOR inhibitor resistance in cancer therapy. Target Oncol 6:17–27 (Review)

5. Chandele A, Prasad V, Jagtap JC et al (2004) Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. Neoplasia 6:29–40

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells;BioImpacts;2023-07-01

2. Antitumor and Complementary Effects of Original Konjac Jelly Mixed with Soymilk, Cheese and Vitamin C for Cisplatin-resistant Bladder Cancer;Japanese Journal of Complementary and Alternative Medicine;2022-03-31

3. Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment;Journal of Cancer Research and Clinical Oncology;2021-12-03

4. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma;Journal of Experimental & Clinical Cancer Research;2021-08-12

5. Insulin reverses choriocarcinoma 5- fluorouracil resistance;Bioengineered;2021-01-01